北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (5): 756-759. doi: 10.3969/j.issn.1671-167X.2017.05.003

• 获奖工作综述 • 上一篇    下一篇

儿童晕厥诊断和治疗进展

徐文瑞1, 廖莹1, 金红芳1, 张清友1, 唐朝枢2, 杜军保1   

  1. 1. 北京大学第一医院儿科, 北京 100034;
    2. 北京大学基础医学院生理学与病理生理学系, 北京 100191
  • 收稿日期:2017-06-10 出版日期:2017-10-18 发布日期:2017-10-18
  • 基金资助:
    国家十二五科技支撑计划(2012BA103B03)、首都医学发展基金重点支持项目(2007-2003)、首都医学发展基金自主创新项目(2002-3037)、首都临床特色应用研究(Z121107001012051,D10100050010059)、首都十大危险疾病科技成果推广专项(Z11110006140000)及北京市科技计划课题(Z171100001017253)资助; 2007年教育部科技进步一等奖(儿童晕厥临床诊治的综合研究), 2007年宋庆龄儿科医学奖(儿童晕厥及其相关疾病的临床研究), 2014年华夏医学科技奖二等奖(提高儿童晕厥诊断和治疗水平的关键技术研究)

Progress in diagnosis and management of syncope in children

XU Wen-rui1, LIAO Ying1, JIN Hong-fang1, ZHANG Qing-you1, TANG Chao-shu2, DU Jun-bao1   

  1. 1. Department of Pediatrics, Peking University First Hospital, Beijing 100034, China;
    2. Department of Physiology and Pathophysiology, Peking University School of Basic Medical Sciences, Beijing 100191, China
  • Received:2017-06-10 Online:2017-10-18 Published:2017-10-18
  • Supported by:
    Supported by the National Twelfth Five-Year-Plan for Scientific and Technological Support Project(2012BA103B03), the Key Program of the Capital Foundation of Medical Developments (2007-2003), the Knowledge Innovation Program of the Capital Foundation of Medical Developments(2002-3037), the Capital Foundation for Clinical Characteristics and Application Research(Z121107001012051,D10100050010059), the Promotional Project of Scientific and Technological Achievements for the Ten Dangerous Diseases in Beijing(Z11110006140000) and the Beijing Science and Technology Plan (Z171100001017253); In 2007, the clinical diagnostic protocol for syncope in children gained the First Prize of Scientific and Technological Progress Award of Ministry of Education, China, and the research progress of syncope in children and the related diseases gained the Soong Ching Ling Foundation Pediatrics Award; In 2014, the research on the key technique of improving the diagnosis and management level of syncope in children gained the Second Prize of Huaxia Medical Science Award

关键词: 儿童晕厥, 诊断流程, 治疗

Abstract: SUMMARY Syncope is a common emergency of children and adolescents, which has serious influence on the quality of life. Neurally-mediated syncope, including postural tachycardia syndrome, vasovagal syncope, orthostatic hypotension and orthostatic hypertension, is the main cause of syncope in children and adolescents. The main manifestations of neurally-mediated syncope are diverse, such as dizziness, headache, chest tightness, chest pain, pale complexion, fatigue, pre-syncope and syncope. Although the clinical manifestations are similar, each subtype of syncope has its hemodynamic feature and optimal treatment option. The diagnosis rate of syncope in children has been greatly improved on account of the development of the diagnostic procedures and methods. In recent years, with the promotion of head-up tilt test and drug-provocated head-up tilt test, the hemodynamic classification of neurally-mediated syncope gets continually refined. In recent years, with the effort of clinicians, an appropriate diagnostic protocol for children with syncope has been established. The initial evaluation consists of history taking, physical examination, standing test and standard electrocardiography. After the initial evaluation, some patients could be diagnosed definitely, such as postural tachycardia syndrome, orthostatic hypotension, and situ-ational syncope. Those with a specific entity causing syncope need selective clinical and laboratory investi-gations. Patients for whom the cause of syncope remained undetermined should undergo head-up tilt test. The precise pathogenesis of neurally-mediated syncope is not entirely clear. In recent years, studies have shown that neurally-mediated syncope may be related to several factors, including hypovolemia, high catecholamine status, abnormal local vascular tension, decreased skeletal muscle pump activity and abnormal neurohumoral factors. Currently based on the possible pathogenesis, the individualized treatment of neurally-mediated syncope has also been studied in-depth. Generally, the management of neurally-mediated syncope includes non-pharmacological and pharmacological interventions. Patient education is the fundamental part above all. In addition to exercise training, the first-line treatments mainly include oral rehydration salts, beta adrenoreceptor blockers, and alpha adrenoreceptor agonists. By analyzing the patient’s physiological indexes and biomarkers before treatment, the efficacy of medication could be well predicted. The individualized treatment will become the main direction in the future researches.

Key words: Syncope, children, Diagnostic protocol, Therapy

中图分类号: 

  • R725.4
[1] 杨锦艳, 王成, 田宏, 等.儿童一过性意识丧失基础疾病谱分析[J].国际儿科学杂志, 2014, 41(2): 195-197, 201.
[2] 中华医学会儿科学分会心血管学组,《中华儿科杂志》编辑委员会,北京医学会儿科学分会心血管学组等.儿童晕厥诊断指南(2016年修订版)[J].中华儿科杂志, 2016, 54(4): 246-250.
[3] Chen L, Li X, Todd O, et a1. A clinical manifestation-based prediction of haemedynamicpottems of orthostatic intolerance in children:a multi-centre study[J]. Cardiol Young, 2014,24(4): 649-653.
[4] Chen L, Zhang Q, Ingrid S, et a1. Aetiology and clinical characteristics of syncope in Chinese children[J].Acta Paediatr, 2007, 96(10): 1505-1510.
[5] 杜军保, 李万镇. 基础直立倾斜试验对儿童不明原因晕厥的诊断研究[J]. 中华儿科杂志, 1997, 35(6): 309-312.
[6] 张清友, 杜军保, 李万镇. 舌下含化硝酸甘油直立倾斜试验对儿童不明原因晕厥的诊断研究[J]. 中华儿科杂志, 2004,42(5): 71.
[7] 张清友, 杜军保, 李万镇. 儿童体位性心动过速综合征的临床特征及随访研究[J]. 中华儿科杂志, 2005, 43(3): 165-169.
[8] 赵娟,杨锦艳,金红芳,等.儿童直立性高血压的临床特征[J].中华儿科杂志, 2012, 50(11): 839-842.
[9] 蔺婧, 王瑜丽, 张清友,等. 儿童青少年晕厥疾病谱近30年变化及卫生经济学分析单中心报告[J]. 中国实用儿科杂志, 2016, 31(5): 350-355.
[10] Zhang Q, Du J, Wang C, et al. The diagnostic protocol in children and adolescents with syncope: a multi-centre prospective study[J].Acta Paediatr, 2009, 98(5): 879-884.
[11] 金红芳, 杨锦艳, 李雪迎, 等. 改良Calgary评分在儿童心源性晕厥和血管迷走性晕厥鉴别诊断中的意义[J]. 中华儿科杂志, 2012, 50(2): 117-120.
[12] Zhang Q, Zhu L, Wang C, et al. Value of history taking in children and adolescents with cardiac syncope[J]. Cardiol Young, 2013, 23(1): 54-60.
[13] Numata T, Abe H, Nagatomo T, et a1. Successful treatment of malignant neurocardiogenic syncope with repeated tilt training program [J]. JpnCirc J, 2000, 64(5): 406-409.
[14] 鲁雯馨,杜军保.体位性心动过速综合征患儿自主神经功能评价与锻炼的研究进展[J].中华儿科杂志, 2015, 53(2): 149-152.
[15] Lu W, Yan H, Wu S, et al. Electrocardiography-derived predictors for therapeutic response to treatment in children with postural tachycardia syndrome[J].J Pediatr, 2016, 176: 128-133.
[16] Hampton JL, Parry SW,Kenny RA, et al. Lower 24 hour urinary sodium concentrations are associated with more severe symptoms in subjects with vasovagal syncope[J]. Heart, 2004, 90(6): 687-688.
[17] Chu W, Wan C, Wu L, et al. Oral rehydration salts: an effective choice for the treatment of children with vasovagal syncope[J]. Pediatr Cardiol, 2015, 36(4): 867-872.
[18] Zhang Q, Liao Y, Tang C, et al. Twenty-four-hour urinary sodium excretion and postural orthostatic tachycardia syndrome[J]. J Pe-diatr, 2012, 161(2): 281-284.
[19] Li H, Wang Y, Liu P, et al. Body mass index (BMI) is associa-ted with the therapeutic response to oral rehydration solution in children with postural tachycardia syndrome[J].Pediatr Cardiol, 2016, 37(7): 1313-1318.
[20] Liao Y, Chen S, Liu X, et al. Flow-mediated vasodilation and endothelium function in children with postural orthostatic tachycardia syndrome [J]. Am J Cardiol, 2010, 106(3): 378-382.
[21] Zhang Q, Du J, Li Y. Endothelial function in children with vasovagal syncope via color Doppler flow imaging[J]. Chin J Pract Pediatr, 2005, 20(8): 482-484.
[22] Zhang Q, Du J, Tang C. The efficacy of midodrine hydrochloride in the treatment of children withvasovagal syncope [J].J Pediatr,2006, 149(6): 777-780.
[23] Zhang F, Li X, Ochs T, et al. Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome [J]. J Am Coll Cardiol, 2012, 60(4): 315-320.
[24] Liao Y, Yang J, Zhang F, et al. Flow-mediated vasodilation as a predictor of therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome[J].Am J Cardiol, 2013, 112(6): 816-820.
[25] Yang J, Zhao J, Du S, et al. Postural orthostatic tachycardia syndrome with increased erythrocytic hydrogen sulfide and response to midodrine hydrochloride[J]. J Pediatr, 2013, 163(4): 1169-1173.
[26] Zhao J, Tang C, Jin H, et al. Plasma copeptin and therapeutic effectiveness of midodrine hydrochloride on postural tachycardia syndrome in children [J]. J Pediatr, 2014, 165(2): 290-294.
[27] Thieben M, Sandroni P, Sletten D, et al. Postural orthostatic tachycardia syndrome: Mayo clinic experience [J]. Mayo Clin Proc, 2007, 82(3): 308-313.
[28] 张凤文, 廖莹, 李雪迎, 等.儿童体位性心动过速综合征美托洛尔和盐酸米多君治疗118例报告[J].中华儿科杂志, 2011, 49(6): 428-432.
[29] 廖莹, 李雪迎, 张燕舞, 等.β受体阻断剂治疗血管迷走性晕厥的Meta分析[J]. 北京大学学报(医学版), 2008, 40(6): 603-609.
[30] Zhang Q, Chen X, Li J, et al. Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome[J]. J Transl Med, 2014,12(1): 249.
[31] Zhao J, Du S, Yang J, et al. Usefulness of plasma copeptin as a biomarker to predict the therapeutic effectiveness of metoprolol for postural tachycardia syndrome in children[J].Am J Cardiol, 2014, 114(4): 601-615.
[32] 中华医学会儿科学分会心血管学组,《中华儿科杂志》编辑委员会.儿童晕厥诊断指南[J].中华儿科杂志, 2009, 47(2): 99-101.
[1] 孟庆伟, 范梦, 郭煌达, 章涵宇, 王梦莹, 王斯悦, 彭和香, 王雪珩, 侯天姣, 秦雪英, 陈大方, 李劲, 武轶群, 吴涛, 陈洪波, 胡永华. 老年人心源性卒中抗凝治疗的预后[J]. 北京大学学报(医学版), 2026, 58(3): 536-542.
[2] 季加孚, 韦静涛, 季科, 步召德. 胃癌诊疗的瓶颈与破局:迈向精准化与智能化融合的新纪元[J]. 北京大学学报(医学版), 2026, 58(2): 231-238.
[3] 王海, 江一舟. 靶向血管治疗在乳腺癌精准治疗中的分子机制与临床应用[J]. 北京大学学报(医学版), 2026, 58(2): 251-256.
[4] 付浩, 申潞艳, 黄冰洋, 马少华. 免疫治疗背景下食管鳞状细胞癌围手术期治疗的临床思考[J]. 北京大学学报(医学版), 2026, 58(2): 266-271.
[5] 刘友东, 吕亚军, 陈杰, 臧明德, 潘宏达, 刘晓文, 陆俊, 刘凤林. 全腹腔镜保留贲门胃底胃次全切除术治疗中上部胃癌的疗效及安全性[J]. 北京大学学报(医学版), 2026, 58(2): 301-306.
[6] 李伟浩, 张学民, 李伟, 张韬, 张小明. 胸主动脉腔内修复术左肱动脉穿刺点使用血管缝合器处理的临床效果[J]. 北京大学学报(医学版), 2026, 58(2): 388-392.
[7] 李嘉临, 陈力侨, 唐家天, 吴艳, 王安强. 胃肝样腺癌转化治疗1例[J]. 北京大学学报(医学版), 2026, 58(2): 399-404.
[8] FarinEbrahimi, 冯志强, FarazEbrahimi, 韩玮华, 于子杨, 贾宽宽, 安金刚. 上颌药物相关性颌骨坏死的不同分期手术治疗效果[J]. 北京大学学报(医学版), 2026, 58(1): 107-114.
[9] 臧海玲, 梁宇红. 上颌第二磨牙慢性根尖周炎合并器械分离的根管再治疗1例[J]. 北京大学学报(医学版), 2026, 58(1): 214-219.
[10] 潘莲菲, 李文静, 王瑞洋, 焦剑, 曹战强, 高丽, 释栋. 口服抗生素辅助牙周机械治疗对重度牙周炎的短期疗效及影响因素[J]. 北京大学学报(医学版), 2026, 58(1): 30-36.
[11] 顾静妍, 李欣艺, 赵金霞, 穆荣. 误诊为类风湿关节炎、痛风的糖尿病致Charcot关节病1例[J]. 北京大学学报(医学版), 2025, 57(6): 1193-1197.
[12] 谢尚, 王鹿鸣, 张馨元, 冯秋实, 夏洋洋, 戴姿薇, 单小峰, 蔡志刚. 口腔鳞癌类器官库的构建及应用[J]. 北京大学学报(医学版), 2025, 57(5): 847-851.
[13] 黄万伟, 沙显燊, 张艺宝, 伍国豪, 骆峰, 陈智慧, 叶东明, 李学松, 赖彩永. 完全3D腹腔镜回肠代双侧输尿管联合膀胱扩大术修复放射治疗后双侧输尿管狭窄并膀胱挛缩[J]. 北京大学学报(医学版), 2025, 57(4): 789-795.
[14] 许秋实, 刘彤, 王俊杰. 铁死亡相关长链非编码核糖核酸预测放射治疗后非小细胞肺癌患者的临床结局[J]. 北京大学学报(医学版), 2025, 57(3): 569-577.
[15] 梁学军, 张凤霞, 靳婷, 祝静静. 长效重组人白介素2药物的生物学活性和抑瘤作用[J]. 北京大学学报(医学版), 2025, 57(2): 253-261.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!